Decisions adopted in the Annual General Meeting of Shareholders of AB K2 LT on 8th of April 2021
Approval of the annual financial statements of AB „K2 LT“ for the year 2020 and presentation of the annual report of AB „K2 LT“ for the year 2020
It was decided to approve the annual financial statements of AB „K2 LT“ for the year 2020 audited by Moore Mackonis, UAB.
The annual report of AB „K2 LT“ for the year 2020, prepared by the Company, assessed by the auditors and approved by the Board of Directors was presented.
Approval of the Board report of AB „K2 LT“ for the year 2020
It was decided to approve the report of the Board of AB „K2 LT“ for the year 2020.
Distribution of the profit of AB „K2 LT“ of 2020
It was decided to distribute AB „K2 LT“ profit of the year 2020 in accordance with the draft of profit distribution presented for the Annual General Meeting of Shareholders (attached). Dividends will not be paid to the shareholders.
Election of the new board member
It was decided to elect Raimondas Gintautas Kriūnas as the board member of the company
Amendments of the Articles of Association of the Company
It was decided:
To expand the competence of the Board of the Company and to this extent amend Article 28 of the Articles of Association to read as follows: “The Board has the right to decide only to enter into an agreement with the consent of the General Meeting of Shareholders. transactions (unilateral, bilateral, multilateral) with a value / amount or liability not exceeding EUR 10 000 000”.
To approve the attached new wording of the Articles of Association (attached)
To authorise the CEO of the Company
Regarding the approval for the development of cremation line 3 and the conclusion of related agreements
It was decided to authorize the Board of the Company and the CEO to conduct negotiations and enter into all and any agreements that will be necessary for the implementation of a new cremation line and that may exceed the limits provided for in Article 28 of the Company's Articles of Association ("The Board has the right to make such transactions without the General Meeting (unilateral, bilateral, multilateral) with a value / amount or commitment not exceeding EUR 150 000 ”), including but not limited to agreement with financial institutions, contractors, designers, material suppliers and others. The Board of the Company is hereby authorized to make the final decision on the conclusion of such aforementioned agreements and their terms. If necessary, the Company provides collateral for the benefit of creditors financing the implementation of the new cremation line.